These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6200811)
1. Suppression by serum of immunoreactivity to a common tumour antigen in cancer patients. Koppi TA; Khan JM; Halliday WJ Oncology; 1984; 41(2):77-82. PubMed ID: 6200811 [TBL] [Abstract][Full Text] [Related]
2. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI). Tsang PH; Roboz JP; Holland JF; Bekesi JG Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478 [TBL] [Abstract][Full Text] [Related]
3. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test]. Ludwig HJ; Storch H Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755 [TBL] [Abstract][Full Text] [Related]
4. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition. Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891 [TBL] [Abstract][Full Text] [Related]
5. Restricted activity of serum blocking factors related to a common tumour antigen in mice. Yong WK; Halliday WJ Oncology; 1983; 40(3):232-7. PubMed ID: 6843950 [TBL] [Abstract][Full Text] [Related]
6. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer. Koide Y; Wakazono K; Yamagata K; Miyaji M; Yamamoto M Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433 [TBL] [Abstract][Full Text] [Related]
7. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays. Dubois AE; Thomson DM; Sutherland ME; Scanzano R Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136 [TBL] [Abstract][Full Text] [Related]
9. Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein. Gouda Z; Thomson DM Jpn J Cancer Res; 1988 Apr; 79(4):529-37. PubMed ID: 2454907 [TBL] [Abstract][Full Text] [Related]
10. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens. Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874 [TBL] [Abstract][Full Text] [Related]
11. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon. Isbister WH N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475 [TBL] [Abstract][Full Text] [Related]
13. Detection of ovarian cancer by the humoral leukocyte adherence inhibition test using a purified tumor-associated antigen. Kotlar HK; Knauf S; Beecham J; Kjørstad K; Sanner T Eur J Cancer Clin Oncol; 1985 Apr; 21(4):483-6. PubMed ID: 3891363 [TBL] [Abstract][Full Text] [Related]
14. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience. Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000 [TBL] [Abstract][Full Text] [Related]
15. Leukocyte adherence inhibition test in lung cancer immunodiagnostic detection. Lodi M; Cavallini G; Pampolini M Ital J Surg Sci; 1988; 18(1):25-34. PubMed ID: 2836338 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the cellular immune response in patients with urinary bladder carcinoma. IV. Leukocyte adherence inhibition tests and leukocyte migration inhibition test (author's transl)]. Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Maekawa M Nihon Hinyokika Gakkai Zasshi; 1979 Mar; 70(3):305-16. PubMed ID: 374815 [No Abstract] [Full Text] [Related]
17. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans. Hellström KE; Hellström I Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919 [TBL] [Abstract][Full Text] [Related]
18. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies. Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475 [TBL] [Abstract][Full Text] [Related]
19. Cell-populations involved in the humoral leukocyte adherence inhibition reaction. The T8-suppressor/cytotoxic cells are both effectors and responders. Moskaug JO; Kotlar HK; Sanner T Eur J Cancer Clin Oncol; 1987 Feb; 23(2):149-56. PubMed ID: 2965016 [TBL] [Abstract][Full Text] [Related]
20. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test]. Okada Y Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]